"Arachidonic Acids" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
No definition found.
| Descriptor ID |
D001095
|
| MeSH Number(s) |
D10.251.355.255.100 D10.251.355.310.166
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Arachidonic Acids".
Below are MeSH descriptors whose meaning is more specific than "Arachidonic Acids".
This graph shows the total number of publications written about "Arachidonic Acids" by people in this website by year, and whether "Arachidonic Acids" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 0 | 1 | 1 |
| 2018 | 0 | 1 | 1 |
| 2019 | 2 | 1 | 3 |
| 2020 | 1 | 2 | 3 |
| 2023 | 0 | 1 | 1 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Arachidonic Acids" by people in Profiles.
-
Late-adolescent onset of prefrontal endocannabinoid control of hippocampal and amygdalar inputs and its impact on trace-fear conditioning behavior. Neuropsychopharmacology. 2024 Aug; 49(9):1417-1424.
-
Metabolomic Effects of Folic Acid Supplementation in Adults: Evidence from the FACT Trial. J Nutr. 2024 02; 154(2):670-679.
-
The endocannabinoid system in humans: significant associations between anandamide, brain function during reward feedback and a personality measure of reward dependence. Neuropsychopharmacology. 2021 04; 46(5):1020-1027.
-
Neural substrates underlying the negative impact of cannabinoid exposure during adolescence. Pharmacol Biochem Behav. 2020 08; 195:172965.
-
Circadian Misalignment of the 24-hour Profile of Endocannabinoid 2-Arachidonoylglycerol (2-AG) in Obese Adults. J Clin Endocrinol Metab. 2020 03 01; 105(3).
-
Impact of circadian rhythmicity and sleep restriction on circulating endocannabinoid (eCB) N-arachidonoylethanolamine (anandamide). Psychoneuroendocrinology. 2020 01; 111:104471.
-
Role of the kynurenine pathway and the endocannabinoid system as modulators of inflammation and personality traits. Psychoneuroendocrinology. 2019 12; 110:104434.
-
Endocannabinoid contributions to alcohol habits and motivation: Relevance to treatment. Addict Biol. 2020 05; 25(3):e12768.
-
Circulating endocannabinoids and affect regulation in human subjects. Psychoneuroendocrinology. 2018 06; 92:66-71.
-
Age-dependent plasticity in endocannabinoid modulation of pain processing through postnatal development. Pain. 2017 Nov; 158(11):2222-2232.